B

Bioatla Inc
NASDAQ:BCAB

Watchlist Manager
Bioatla Inc
NASDAQ:BCAB
Watchlist
Price: 1.71 USD -14.07% Market Closed
Market Cap: 82.7m USD
Have any thoughts about
Bioatla Inc?
Write Note

P/FCFE
Price to FCFE

-1
Current
-1.5
Median
27.3
Industry
Higher than median
Lower than industry value

Price to Free Cash Flow To Equity (P/FCFE) ratio is a valuation multiple that compares a company’s market capitalization to the amount of free cash flow available for equity shareholders. This metric is very similar to the P/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.

P/FCFE
-1
=
Market Cap
82.7m USD
/
FCFE
-85.1m USD
All Countries
Close
Market Cap P/FCFE
US
Bioatla Inc
NASDAQ:BCAB
82.7m USD -1
FR
Pharnext SCA
OTC:PNEXF
6T USD -3 193 097.1
US
Abbvie Inc
NYSE:ABBV
299.8B USD 12
US
Amgen Inc
NASDAQ:AMGN
159.1B USD 26.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
124.7B USD -89.2
US
Gilead Sciences Inc
NASDAQ:GILD
114.8B USD 11.5
US
Epizyme Inc
F:EPE
94.1B EUR -429.7
AU
CSL Ltd
ASX:CSL
133.9B AUD 78.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
86.2B USD 26
US
Seagen Inc
F:SGT
39.3B EUR -59.1
NL
argenx SE
XBRU:ARGX
32.6B EUR -108.2
 
US
B
Bioatla Inc
NASDAQ:BCAB
Average P/FCFE: 31
Negative Multiple: -1
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -3 193 097.1
US
Abbvie Inc
NYSE:ABBV
12
US
Amgen Inc
NASDAQ:AMGN
26.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -89.2
US
Gilead Sciences Inc
NASDAQ:GILD
11.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -429.7
AU
CSL Ltd
ASX:CSL
78.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
26
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.1
NL
argenx SE
XBRU:ARGX
Negative Multiple: -108.2

P/FCFE Forward Multiples

Forward P/FCFE multiple is a version of the P/FCFE ratio that uses forecasted free cash flow to equity for the P/FCFE calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to equity forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/FCFE
N/A
2-Years Forward
P/FCFE
N/A
3-Years Forward
P/FCFE
N/A

See Also

Discover More